Thanks and yes - definitely do not panic. So long as US OLE and Expanded Access is around and Brazil trials just got final approval - we have enough evidence that signal is strong and we need to see it through.
If the SEC/DOJ investigation was about whether the drug works or not we should have seen patient access restrictions by now and Brazil should not have approved commencement of trials.
It's going to get dirtier but this is where the intersection with fun resides anyway.
Market Data 
Markets 
AI
